Literature DB >> 15032600

Interleukin-10 and related cytokines and receptors.

Sidney Pestka1, Christopher D Krause, Devanand Sarkar, Mark R Walter, Yufang Shi, Paul B Fisher.   

Abstract

The Class 2 alpha-helical cytokines consist of interleukin-10 (IL-10), IL-19, IL-20, IL-22, IL-24 (Mda-7), and IL-26, interferons (IFN-alpha, -beta, -epsilon, -kappa, -omega, -delta, -tau, and -gamma) and interferon-like molecules (limitin, IL-28A, IL-28B, and IL-29). The interaction of these cytokines with their specific receptor molecules initiates a broad and varied array of signals that induce cellular antiviral states, modulate inflammatory responses, inhibit or stimulate cell growth, produce or inhibit apoptosis, and affect many immune mechanisms. The information derived from crystal structures and molecular evolution has led to progress in the analysis of the molecular mechanisms initiating their biological activities. These cytokines have significant roles in a variety of pathophysiological processes as well as in regulation of the immune system. Further investigation of these critical intercellular signaling molecules will provide important information to enable these proteins to be used more extensively in therapy for a variety of diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15032600     DOI: 10.1146/annurev.immunol.22.012703.104622

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  362 in total

1.  Alveolar macrophages in neonatal mice are inherently unresponsive to Pneumocystis murina infection.

Authors:  Cathryn Kurkjian; Melissa Hollifield; J Louise Lines; Amy Rogosky; Kerry M Empey; Mahboob Qureshi; Stephen A Brown; Beth A Garvy
Journal:  Infect Immun       Date:  2012-06-04       Impact factor: 3.441

2.  Il-19 reduces VSMC activation by regulation of mRNA regulatory factor HuR and reduction of mRNA stability.

Authors:  Anthony A Cuneo; David Herrick; Michael V Autieri
Journal:  J Mol Cell Cardiol       Date:  2010-05-06       Impact factor: 5.000

Review 3.  Structure and function of interleukin-22 and other members of the interleukin-10 family.

Authors:  Daniela Barretto Barbosa Trivella; José Ribamar Ferreira-Júnior; Laure Dumoutier; Jean-Christophe Renauld; Igor Polikarpov
Journal:  Cell Mol Life Sci       Date:  2010-05-08       Impact factor: 9.261

4.  Using Linear Discriminant Analysis to Characterize Novel Single Nucleotide Polymorphisms and Expression Profile Changes in Genes of Three Breeds of Rabbit (Oryctolagus cuniculus).

Authors:  Ahmed I Ateya; Basma M Hendam; Hend A Radwan; Eman A Abo Elfadl; Mona M Al-Sharif
Journal:  Comp Med       Date:  2021-05-25       Impact factor: 0.982

Review 5.  Rosacea: The cytokine and chemokine network.

Authors:  Peter Arne Gerber; Bettina Alexandra Buhren; Martin Steinhoff; Bernhard Homey
Journal:  J Investig Dermatol Symp Proc       Date:  2011-12

6.  Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation.

Authors:  Ashutosh Chaudhry; Robert M Samstein; Piper Treuting; Yuqiong Liang; Marina C Pils; Jan-Michael Heinrich; Robert S Jack; F Thomas Wunderlich; Jens C Brüning; Werner Müller; Alexander Y Rudensky
Journal:  Immunity       Date:  2011-04-22       Impact factor: 31.745

Review 7.  Cytokine-receptor interactions as drug targets.

Authors:  Gideon Schreiber; Mark R Walter
Journal:  Curr Opin Chem Biol       Date:  2010-07-07       Impact factor: 8.822

8.  IL-21 mediates suppressive effects via its induction of IL-10.

Authors:  Rosanne Spolski; Hyoung-Pyo Kim; Wei Zhu; David E Levy; Warren J Leonard
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

9.  Melanoma differentiation-associated gene-7/interleukin-24 as a potential prognostic biomarker and second primary malignancy indicator in head and neck squamous cell carcinoma patients.

Authors:  Lin Wang; Zhien Feng; Huanhuan Wu; Shuai Zhang; Yinfei Pu; Huan Bian; Yixiang Wang; Chuanbin Guo
Journal:  Tumour Biol       Date:  2014-08-05

10.  IL-19 reduces ligation-mediated neointimal hyperplasia by reducing vascular smooth muscle cell activation.

Authors:  Stephen Ellison; Khatuna Gabunia; James M Richards; Sheri E Kelemen; Ross N England; Dan Rudic; Yasu-Taka Azuma; M Alexandra Munroy; Satoru Eguchi; Michael V Autieri
Journal:  Am J Pathol       Date:  2014-05-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.